k Immunotherapy for cancer scientist examining wells containing cell cultures of lymphocytes that have been doped with Interleukin2 IL2 for possible contamination. IL2 is released naturally by certain key cells of the immune system T lymphocytes after they have been activated by foreign antigens of cancer cells, for instance. IL2 amplifies the proliferation of other cell types, including lymphokineactivated natural killer LANAK cells that attack cancer cells directly. In this technique, blood is removed, doped with IL2 cultured in vitro for 34 weeks to raise the population of LANAK cells. The product is then reinjected into the patient. Photographed at Institut Gustave Roussy, Villejuif, France, 198889. Editorial Stock Photo - Afloimages
Sign up
Login
All images
Immunotherapy for cancer: scientist examining wells containing cell cultures of lymphocytes that have been doped with Interleukin-2 (IL-2) for possible contamination. IL-2 is released naturally by certain key cells of the immune system (T- lymphocytes) after they have been activated by foreign antigens - of cancer cells, for instance. IL-2 amplifies the proliferation of other cell types, including lymphokine-activated natural killer (LANAK) cells that attack cancer cells directly. In this technique, blood is removed, doped with IL-2 & cultured in vitro for 3-4 weeks to raise the population of LANAK cells. The product is then re-injected into the patient. Photographed at Institut Gustave Roussy, Villejuif, France, 1988/89.
ED

Immunotherapy for cancer: scientist examining wells containing cell cultures of lymphocytes that have been doped with Interleukin-2 (IL-2) for possible contamination. IL-2 is released naturally by certain key cells of the immune system (T- lymphocytes) after they have been activated by foreign antigens - of cancer cells, for instance. IL-2 amplifies the proliferation of other cell types, including lymphokine-activated natural killer (LANAK) cells that attack cancer cells directly. In this technique, blood is removed, doped with IL-2 & cultured in vitro for 3-4 weeks to raise the population of LANAK cells. The product is then re-injected into the patient. Photographed at Institut Gustave Roussy, Villejuif, France, 1988/89.

Details

ID
10585487

Collection

License type
Editorial

Photographer

Creation date
16-11-2010

Contact Aflo for all commercial uses.


Keywords
More
Sign in
Member access
Login not found.